B BRENUS PHARMA
Live / Registered — Registered (as of 23 Nov 2021)
What this means for you
Registered since 23 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79296944
- Registration number
- 6564692
- Mark type
- Design + words
- Filed
- 25 Aug 2020
- Published for opposition
- 07 Sept 2021
- Registered
- 23 Nov 2021
- Attorney of record
- Adam Weiss
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for treating pathologies that are controllable or curable by stimulated immunological reaction from a patient, namely, through infectious or oncological diseases; Veterinary products, namely, veterinary preparations for treating pathologies that are controllable or curable by stimulated immunological reaction from an animal, namely, through infectious or oncological diseases; Chemical preparations for pharmaceutical purposes, namely, for treating pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Biological preparations for medical or therapeutic purposes, namely, preparations for the treatment of pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Biological preparations for veterinary purposes, namely, preparations for the treatment of pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Pharmaceutical preparations, namely, immune system aids for use in human medicine; Diagnostic preparations for medical use; Diagnostic preparations for veterinary use; Immunostimulants under the pharmaceutical monopoly; medicines in the nature of vaccinal administrations for stimulating the immune system for use in human medicine; Serums under the pharmaceutical monopoly for medical purposes, namely, pharmaceutical serums for the treatment of the immune system; Biocellular preparations for therapeutic or medical purposes, namely, pharmaceutical preparations for the treatment of the immune system
Owner
- BRENUS PHARMA, FR
- BRENUS PHARMA, FR
- BRENUS PHARMA, FR
Prosecution history
- 24 Jul 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Jun 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 May 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 11 May 2022 — FINAL DISPOSITION PROCESSED
- 23 Feb 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 23 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 11 Sept 2021 — NOTIFICATION PROCESSED BY IB
- 07 Sept 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Sept 2021 — PUBLISHED FOR OPPOSITION
- 23 Aug 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 18 Aug 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 18 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Aug 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Aug 2021 — EXAMINER'S AMENDMENT ENTERED
- 03 Aug 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED